171 related articles for article (PubMed ID: 16169484)
21. [Proliferation inhibition effect of indomethacin on CML cells associated with down-regulation of phosphorylated STAT1/STAT5 and inhibition of COX-2 expression].
Zhang GS; Fu YB; Xia M
Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):732-5. PubMed ID: 15730717
[TBL] [Abstract][Full Text] [Related]
22. Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells.
Blasius R; Reuter S; Henry E; Dicato M; Diederich M
Biochem Pharmacol; 2006 Nov; 72(11):1547-54. PubMed ID: 16959222
[TBL] [Abstract][Full Text] [Related]
23. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
24. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
[TBL] [Abstract][Full Text] [Related]
25. Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2.
Wang J; Jiang D; Zhang H; Lv S; Rao H; Fei R; Wei L
Proteomics; 2009 Mar; 9(6):1672-82. PubMed ID: 19242931
[TBL] [Abstract][Full Text] [Related]
26. Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells.
Khodarev NN; Minn AJ; Efimova EV; Darga TE; Labay E; Beckett M; Mauceri HJ; Roizman B; Weichselbaum RR
Cancer Res; 2007 Oct; 67(19):9214-20. PubMed ID: 17909027
[TBL] [Abstract][Full Text] [Related]
27. Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1.
Lui VW; Boehm AL; Koppikar P; Leeman RJ; Johnson D; Ogagan M; Childs E; Freilino M; Grandis JR
Mol Pharmacol; 2007 May; 71(5):1435-43. PubMed ID: 17325127
[TBL] [Abstract][Full Text] [Related]
28. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE
J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971
[TBL] [Abstract][Full Text] [Related]
30. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
31. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells.
Lynch RA; Etchin J; Battle TE; Frank DA
Cancer Res; 2007 Feb; 67(3):1254-61. PubMed ID: 17283162
[TBL] [Abstract][Full Text] [Related]
32. Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.
Heise R; Amann PM; Ensslen S; Marquardt Y; Czaja K; Joussen S; Beer D; Abele R; Plewnia G; Tampé R; Merk HF; Hermanns HM; Baron JM
PLoS One; 2016; 11(1):e0146325. PubMed ID: 26735690
[TBL] [Abstract][Full Text] [Related]
33. The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFNalpha on pleomorphic sarcoma cells.
Gazziola C; Cordani N; Carta S; De Lorenzo E; Colombatti A; Perris R
Int J Oncol; 2005 Jan; 26(1):129-40. PubMed ID: 15586233
[TBL] [Abstract][Full Text] [Related]
34. Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death.
Choi HJ; Lui A; Ogony J; Jan R; Sims PJ; Lewis-Wambi J
Breast Cancer Res; 2015 Jan; 17(1):6. PubMed ID: 25588716
[TBL] [Abstract][Full Text] [Related]
35. The Chemopreventive Phytochemical Moringin Isolated from Moringa oleifera Seeds Inhibits JAK/STAT Signaling.
Michl C; Vivarelli F; Weigl J; De Nicola GR; Canistro D; Paolini M; Iori R; Rascle A
PLoS One; 2016; 11(6):e0157430. PubMed ID: 27304884
[TBL] [Abstract][Full Text] [Related]
36. Interferon-gamma-mediated growth regulation of melanoma cells: involvement of STAT1-dependent and STAT1-independent signals.
Kortylewski M; Komyod W; Kauffmann ME; Bosserhoff A; Heinrich PC; Behrmann I
J Invest Dermatol; 2004 Feb; 122(2):414-22. PubMed ID: 15009724
[TBL] [Abstract][Full Text] [Related]
37. STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-α.
Machiraju D; Moll I; Gebhardt C; Sucker A; Buder-Bakhaya K; Schadendorf D; Hassel JC
Melanoma Res; 2018 Jun; 28(3):204-210. PubMed ID: 29485532
[TBL] [Abstract][Full Text] [Related]
38. Translational and post-translational modifications of proteins as a new mechanism of action of alpha-interferon: review article.
Caraglia M; Vitale G; Marra M; Del Prete S; Lentini A; Budillon A; Beninati S; Abbruzzese A
Amino Acids; 2004 Jul; 26(4):409-17. PubMed ID: 15290347
[TBL] [Abstract][Full Text] [Related]
39. The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line.
Badgwell B; Lesinski GB; Magro C; Abood G; Skaf A; Carson W
J Surg Res; 2004 Jan; 116(1):129-36. PubMed ID: 14732359
[TBL] [Abstract][Full Text] [Related]
40. Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2.
Sim GC; Wu S; Jin L; Hwu P; Radvanyi LG
Oncotarget; 2016 Jun; 7(24):36074-36091. PubMed ID: 27153543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
